Boehringer Tries To Derail Mirapex Antitrust Suits
Boehringer Ingelheim International GmbH has moved to dismiss two antitrust suits brought by rival Mylan Inc. and direct buyers that accuse the generics maker of knowingly prosecuting an invalid patent for...To view the full article, register now.
Already a subscriber? Click here to view full article